Paolo Tarantino: Recap of the first 40 years of ADC development – OncoDaily
Paolo Tarantino: Recap of the first 40 years of ADC development / AACR25, ADC development, antibody, cancer, Cancer Discovery, drug conjugates, fight against
Related Articles
HR+/HER2- MBC 2L Outcomes: Top 10 ASCO 2025 Breakthroughs
Explore HR+/HER2- metastatic breast cancer 2L outcomes with crucial insights from ASCO 2025 on median progression-free survival.
Petros Grivas: Best of ASCO in Seattle – OncoDaily
Petros Grivas: Best of ASCO in Seattle / Binaytara, cancer, OncoDaily, Oncology, Petros Grivas, University of Washington and Seattle Cancer Care Alliance
Bispecific Antibodies Cancer Therapy: 2025 Advances
Discover BsAb oncology & 2025 clinical trials. Explore bispecific antibodies cancer therapy on OncologyTube.com. Watch now!
Myeloma Paper of the Day, June 16th, suggested by Robert Orlowski – OncoDaily
Myeloma Paper of the Day, June 16th, suggested by Robert Orlowski / Abderrazak El Yamani, Adrienne de Labarthe, Alexis Talbot, Arthur Bobin, Aurore Perrot,
China Leads Oncology Trials with 39% Share | OncologyTube
Explore how China oncology trials are revolutionizing cancer research with a remarkable increase in clinical trials.
PROTAC Targeting LZK Shows Promise for Treating HNSCC – NCI Center for Cancer Research – OncoDaily
PROTAC Targeting LZK Shows Promise for Treating HNSCC – NCI Center for Cancer Research / Amy L Funk, Anna A Marusiak, cancer, Carolyn C Woodroofe,…
7 Posts Not to Miss From the EHA 2025 – Nico Gagelmann – OncoDaily
7 Posts Not to Miss From the EHA 2025 – Nico Gagelmann / 30th EHA Annual Congress, EHA 2025, Hematology, Nico Gagelmann, The European Hematology…
HCC Treatment Selection: 2025 ASCO Video Guide
Explore HCC treatment selection with guidelines from ASCO 2025 to improve patient outcomes and management of hepatocellular carcinoma.